Xylocaine Injection, Solution
Product Images NDC 63323-482

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 63323-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xyl02 0001 01

FDA Label Image

Xyl02 0001 02

FDA Label Image

Xyl02 0001 03

FDA Label Image

Xyl02 0001 04

FDA Label Image

Xyl02 0001 05

This is a description of Xylocaine® - a drug with lidocaine HCI and epinephrine Injection , USP mixture that can be used for infiltration and nerve block but not recommended for Caudal or Epidural Use. The package comes with a 20 mL multiple Dose Vial meant for R only. The drug is sterile, nonpyrogenic, and should not be autoclaved. Usage of the injection should be avoided if it contains a precipitate or pinkish color. For storage, the drug must be protected from light and stored at a temperature of 20° to 25°C (68° to 77°F). The manufacturers of Xylocaine® are Fresenius Kabi, located in Lake Zurich, IL.*

FDA Label Image

Xyl02 0001 06

Xylocaine® (lidocaine HCI and epinephrine) is an injection used for infiltration and nerve block but not for caudal or epidural use. It is to be sold only as an unbroken package in 25 multiple dose vials of 20 mL each. The injection is sterile and nonpyrogenic and should be protected from light. Each mL contains lidocaine HCI 10 mg, epinephrine (as the bitartrate) 0.01 mg, citric acid 02mg, sodium chioride 7mg, sodium metabisulfite 05mg, and methylparaben 1mg. The brand names mentioned in this document are the trademarks of their respective owners. PremierProRX® is a registered trademark of Premier Healthcare Aliance, L.P., used under license. It is manufactured by Fresenius Kabi and should be stored at 20° to 25°C (68° to 77°F).*

FDA Label Image

Xyl02 0001 07

NDC 63323-485-41 PRX480527 Sterile, nonpyrogenic Lidocaine HCl Injection, USP is a medication used for Infiltration and Nerve Block, but not for Caudal or Epidural use. It is a solution containing 200 mg per 20 mL and can be resterilized by autoclaving. It should not be used if the solution is discolored or contains a precipitate. It is stored at 20° to 25°C (68° to 77°F) and should be kept in a controlled room temperature. It is Rx only and comes in a 20 mL multiple-dose vial. The medication is manufactured by PREMIERProRx® and more information can be found at www.fresenius-kabi.com/us.*

FDA Label Image

Xyl02 0001 08

This is a description of Xylocaine, which is a lidocaine HCI injection for infiltration and nerve block, not for caudal or epidural use. It comes in 25 multiple dose vials of 20 mL each, with each mL containing 10 mg of Lidocaine HCI, 7 mg of sodium chloride, and 1mg of methylparaben. The pH is adjusted to approximately 6.5. It can be resterilized by autoclaving. The package insert should be consulted for dosage information. It should not be used if the solution is discolored or contains a precipitate. It should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F). The trademark mentioned is PREMIERProRx, registered under Premier Healthcare Alliance, L.P., used under license. There is no other information available.*

FDA Label Image

Xyl02 0001 09

This is a description of Xylocaine, a lidocaine HCI injection which is used for infiltration and nerve block. It comes in a 20 mL multiple dose vial and is not to be used for caudal or epidural use. It is manufactured by Fresenius Kabi and can be resterilized by autoclaving. The solution should not be used if discolored or contains a precipitate and should be stored at a controlled room temperature according to USP guidelines.*

FDA Label Image

Xyl02 0001 10

Xylocaine is an injection medication containing lidocaine HCI, used for infiltration and nerve block; not for caudal or epidural use. It is a sterile, nonpyrogenic and can be resterilized by autoclaving. It is available in 25 multiple dose vials of 20 mL with each mL containing 20 mg of lidocaine HCI, 6 mg of sodium chloride, and 1mg of methylparaben. The pH is adjusted using sodium hydroxide and/or hydrochloric acid to approximately 6.5-7.0. Dosage and full prescribing information are available in the package insert. It is to be stored at 20°C to 25°C and should not be used if the solution is discolored or has a precipitate. This medication is manufactured and marketed by Fresenius Kabi in Lake Zurich, IL.*

FDA Label Image

Xyl02 0001 11

This is a description for a medication called Xylocaine-MPF, which contains lidocaine HCI injection, USP. It is used for infiltration and nerve block, including caudal and epidural use. It comes in a 2mL single-dose vial and is manufactured by Fresenius Kabi in Lake Zurich, IL. It is methylparaben-free. The NDC number is 63323-492-41 and the lot/exp number is 403158A.*

FDA Label Image

Xyl02 0001 12

This is a description of Xylocaine-MPF, a sterile, nonpyrogenic lidocaine injection used for infiltration and nerve block, including caudal and epidural forms of screening. It is available in single-dose vials containing 2mL of 10mg/mL lidocaine hydrochloride and is intended for use after adjusting the pH to 6.5 (5.0 to 7.0) with sodium hydroxide and/or hydrochloric acid. It can be resterilized by autoclaving but should not be used if the solution is cloudy, discolored, or contains a precipitate. The product is manufactured by Fresenius Kabi and should be stored at 20° to 25°C (68° to 77°F). The mentioned brand names are trademarks of their respective owners, and PREMIERProRx® is a registered trademark of Premier Healthcare Aliance, L.P., used under license.*

FDA Label Image

Xyl02 0001 13

This is a description for Xylocaine-MPF, which is an injection medication made from lidocaine HCI. It is available in a 5mL single dose vial and should not be used if the solution is discolored or has a precipitate. It is used for infiltration and nerve block, including caudal and epidural use, and is methylparaben free. The medication should be stored between 20-25°C. The manufacturer is Fresenius Kabi and it is only available with a prescription. For more information, visit their website.*

FDA Label Image

Xyl02 0001 14

Xylocaine-MPF is a lidocaine HC injection used for infiltration and nerve blocks, including caudal and epidural use. The medication is Methylparaben-free and each vial contains 10mg of Lidocaine HCI and 7mg of Sodium chloride. It should be stored at 20° to 25°C (68° to 77°F) and should not be used if the solution is discolored or contains a precipitate. The medication can be re-sterilized by autoclaving. Full prescribing information is available in the package insert. The medication is manufactured by Fresenius Kabi and comes in a package of 25 single dose vials.*

FDA Label Image

Xyl02 0001 15

Xylocaine-MPF is a sterile, non-pyrogenic lidocaine HCl injection used for infiltration and nerve blocks, including caudal and epidural use. It comes in a 5mL single dose vial that is methylparaben free and can be resterilized by autoclaving. The product should not be used if it is discolored or contains a precipitate. It should be stored at 20° to 25°C. It is manufactured by Fresenius Kabi and more information can be found at their website. The LOT/EXP information is not available.*

FDA Label Image

Xyl02 0001 16

NDC 63323-495-26 PRX491507 is a sterile, nonpyrogenic Lidocaine HCl Injection solution used for nerve block, epidural and infiltration procedures. It is available in 5 mL single-use vials and should be discarded if the solution is discolored or contains a precipitate. The solution can be resterilized by autoclaving. This product is a registered trademark of Premier Healthcare Alliance, L.P. and should only be sold as an unbroken package. For full prescribing and dosage information, consult the package insert.*

FDA Label Image

Xyl02 0001 17

Xylocaine®-MPF (lidocaine HCI Injection, USP) is a drug that is sterile, non-pyrogenic, and can be resterilized by autoclaving. This drug is intended for infiltration and nerve block, as well as caudal and epidural use. The package contains one single-dose vial of 30 mL, and the drug has a concentration of 300 mg per 30 mL. This medication is methylparaben-free and should not be used if the solution is discolored or contains a precipitate. The unused portion of the vial should be discarded, and the drug should be stored at a temperature between 20° to 25°C (68° to 77°F). Note that the drug is only available through prescription.*

FDA Label Image

Xyl02 0001 18

Xylocaine-MPF is a lidocaine HCI injection used for infiltration and nerve block including caudal and epidural use. It is methylparaben free, sterile, and nonpyrogenic. Each mL of the injection contains Lidocaine HCI (10 mg) and Sodium chloride (7mg). It comes in a package with 25 single-dose vials, each vial containing 30 mL of solution. The solution can be resterilized by autoclaving but should not be used if it is discolored or contains a precipitate. Unused portions must be discarded, and the injection must be stored between 20 to 25°C. Refer to the package insert for dosage and full prescribing information. The product is manufactured by Fresenius Kabi, Lake Zurich, IL 60047.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.